PDCD1 and neoplasm: Importantly, inhibition of EGF-mediated PD-L1 stabilization enhances a therapeutic efficacy of PD-1 blockade to promote tumour-infiltrating cytotoxic T-cell immune response (Fig. 5i and Supplementary Fig. 9c–g).